Effect of forearm and posterior wall anastomosis on gastroesophageal reflux in proximal gastrectomy patients

Table 1 Pre- and post-treatment gastroesophageal reflux disease questionnaire scores and reflux symptom scores in observation and control groups, mean ± SD

Measurement	Observation group	Control group	t value	P value
GerdQ score pre-treatment	14.66 ± 1.66	14.62 ± 1.71	0.08	0.95
GerdQ score post-treatment	7.32 ± 1.101	10.35 ± 1.371	7.191	< 0.001
Reflux symptom pre-treatment	3.27 ± 1.17	3.24 ± 1.10	0.09	0.94
Reflux symptom post-treatment	1.13 ± 0.641	1.97 ± 0.901	3.168	0.002
Regurgitation pre-treatment	1.97 ± 0.88	1.96 ± 0.84	0.04	0.98
Regurgitation post-treatment	0.93 ± 0.221	1.42 ± 0.471	3.971	< 0.001
Retrosternal pain pre-treatment	1.64 ± 0.58	1.65 ± 0.59	0.06	0.96
Retrosternal pain post-treatment	0.63 ± 0.251	1.18 ± 0.341	5.446	< 0.001
Belching pre-treatment	2.17 ± 0.64	2.20 ± 0.59	0.16	0.88
Belching post-treatment	0.66 ± 0.251	1.40 ± 0.331	8.273	< 0.001

¹Comparisons within the same group pre- and post-treatment are marked with an asterisk, indicating a statistically significant difference with a P value less than 0.05.

GerdQ: Gastroesophageal reflux disease questionnaire.

Table 2 Diamine oxidase, D-lactic, and endotoxin levels pre- and post-treatment in observation and control groups

Measurement	Pre-treatment observation	Post-treatment observation	Pre-treatment control	Post-treatment control	t value	P value
DAO (IU/L)	1.53 ± 0.24	2.25 ± 0.501	1.56 ± 0.28	3.18 ± 0.621	5.409	< 0.01
D-lactic (mg/L)	2.78 ± 0.56	3.44 ± 0.761	2.72 ± 0.54	4.29 ± 0.871	3.357	< 0.01
ETX (EU/mL)	0.41 ± 0.14	1.36 ± 0.331	0.39 ± 0.16	1.71 ± 0.451	3.451	< 0.01

¹Comparisons within the same group pre- and post-treatment are marked with an asterisk, indicating a statistically significant difference with a P value less than 0.05.

DAO: Diamine oxidase; ETX: Endotoxin.

Table 3 Levels of serum ferritin, prealbumin, and albumin pre- and post-treatment in observation and control groups

Measurement	Pre-treatment observation	Post-treatment observation	Pre-treatment control	Post-treatment control	t value	P value
SF (µg/L)	94.67 ± 10.90	82.54 ± 11.671	95.40 ± 10.99	74.28 ± 9.661	2.519	0.016
PA (mg/L)	254.82 ± 18.31	236.44 ± 17.881	255.94 ± 18.33	220.18 ± 14.791	3.237	< 0.01
ALB (g/L)	40.54 ± 4.40	38.73 ± 3.65	39.98 ± 3.99	35.08 ± 3.651	4.173	< 0.01

¹Comparisons within the same group pre- and post-treatment are marked with an asterisk, indicating a statistically significant difference with a P value less than 0.05.

SF: Serum ferritin; PA: Prealbumin; ALB: Albumin.